ObjectiveTo systematically review the relationship between polycyclic aromatic hydrocarbons (PAHs) and emotion and behaviors in children and adolescents. MethodsThe PubMed, EBSCO, Web of Science, CBM, VIP, WanFang Data, OVFT, Proquest Psychological database and CNKI databases were electronically searched to collect studies on the relationship between PAHs and emotion and behaviors in children and adolescents from inception to October 20, 2022. Two reviewers independently screened the literature, extracted data and assessed the risk of bias of the included studies. A qualitative systematic review was then performed. ResultsA total of six cohort studies were included, five studies involving maternal exposure during pregnancy, found that maternal exposure to PAHs during pregnancy was associated with an increase in childhood anxiety/depression syndrome, attention problems, social withdrawal, social competence, social problems, orientation/regulation, withdrawal behaviors, and autism-related behaviors. Another study of exposure in school-age children found that PAHs exposure was associated with poorer attention performance in school. Results of other emotional behaviors were inconsistent, or no association was found. ConclusionCurrent evidence shows that PAHs have certain effects on emotional behaviors of children and adolescents. Due to the limited quality and quantity of the included studies, more high-quality cohort studies are required to verify above conclusion.
Objective The aim of this article is to analyze the clinical characteristics of intra-abdominal aggressive fibromatosis and discuss its treatment methods. Methods Retrospective analysis of the clinical data in 8 cases of intra-abdominal aggressive fibromatosis who were confirmed by surgery and pathological diagnosis between Feb. 2011 and Mar. 2017 in Shengjing hospital was performed. Results Of the 8 cases (3 males and 5 females), there were 4 cases of simple abdominal pain (2 cases of repeated intermittent abdominal pain and 2 cases of acute abdominal pain), 3 cases of abdominal mass, and 1 case of relapses after surgery in outside hospital (others 7 cases were the first visit). The course of disease was 4 to 720 d, with median of 130 d. All cases underwent radical surgery, and the operative time was 92 to 493 min, with an average of 246 min. Intraoperative blood loss was 20 to 1 000 mL, with an average of 321 mL. The drainage tube placement time in all patients was 5 to 9 d, with an average of 6 d. The hospital stay was 11 to 75 d, with an average of 25 d. Two cases suffered from postoperatively appeared abdominal pain symptoms. All cases were followed-up for 6 to 40 months, with median of 23 months. During the follow-up period, 1 case relapsed on 212 dafter surgery, and the remaining 7 cases had no recurrence. Conclusion For intra-abdominal aggressive fibromatosis, it is difficult to make clear diagnosis before operation and surgery is the primary choice of treatment when symptom appeared.
【摘要】 目的 探討經陰道彩色多普勒超聲診斷子宮內膜息肉的價值，進一步提高子宮內膜息肉的診斷準確率。 方法 2009年1月-2010年12月，對48例子宮內膜息肉患者，經陰道彩色多普勒超聲發現病灶后觀察其位置、大小、內部回聲及病灶內部和周邊的彩色血流情況，并與手術病理結果對照。 結果 經陰道彩色多普勒超聲診斷子宮內膜息肉的準確率為87.5%， 2例誤診為子宮黏膜下肌瘤，3例誤診為子宮內膜增厚，1例漏診。 結論 經陰道彩色多普勒超聲對子宮內膜息肉有較高的臨床診斷價值。【Abstract】 Objective To investigate the value of transvaginal color doppler ultrasonography in the diagnosis of endometrial polyps and to further improve the diagnostic accuracy. Methods From January 2009 to December 2010, fourty-eight patients with endometrial polyps participated in this study. Transvaginal color doppler ultrasonography was used to observe the location, size, and internal echo of the lesions, and the color flow within and around the lesions. Then, we compared all the ultrasonic features with pathological findings. Results The diagnostic accuracy of transvaginal color doppler ultrasonography in the diagnosis of endometrial polyps was 87.5%. Two cases were misdiagnosed as submucosal uterine fibroids, 3 as endometrial thickening, and 1 missed. Conclusion Transvaginal color doppler ultrasonography has a high clinical value in the diagnosis of endometrial polyps.
Objective To investigate the feasibility and safety of laparoscopic operation of gastric and gastroesophageal junction diseases. Methods Between May 2004 and June 2009, 59 patients with gastric and gastroesophageal diseases were treated laparoscopically. The operative methods and maneuvers were evaluated and perioperative interventions, complications and efficacy of patients were analyzed. Results All operations were successfully completed laparoscopically except for one patient with gastric cancer who required a conversion to open surgery. No short-term complications occurred in all cases. No port transplant metastasis occurred for the patients with gastric cancer after an average of 36 months (1-60 months) follow-up. One patient died of liver metastasis 12 months after operation. The 3-year survival rate was 93.3% (14/15). Conclusion Laparoscopic surgery of the gastric and gastroesophageal junction diseases is feasible and safe with minimal invasiveness, which is worth popularizing.
目的 探討利用常規腹腔鏡器械完成經臍單孔腹腔鏡結直腸手術的可能性和技術要點。方法 收集中國醫科大學附屬盛京醫院微創外科于2009年4月至2010年1月期間施行的12例經臍單孔腹腔鏡結直腸手術的臨床資料。闌尾炎8例，均為女性，平均年齡40歲； 回盲部腫物2例，均為女性，其中1例為回盲部淋巴水瘤（68歲），另1例為回盲部潰瘍性結腸炎（47歲）； 乙狀結腸息肉1例，女，55歲； 直腸癌1例，男，52歲。 12例均于臍部行2.5~3.0 cm長單切口，利用常規腹腔鏡手術器械完成手術。結果 8例闌尾手術，手術時間20~50 min，出血量均少于10 ml； 2例回盲部切除術手術時間分別為60 min和90 min，出血量分別為10 ml和20 ml； 1例乙狀結腸切除術用時120 min，術中出血約50 ml，術后4 d拔除引流管； 直腸癌手術時間210 min，術中出血少于200 ml，術后1周拔除引流管并出院。結論 利用常規腹腔鏡手術器械完成經臍單孔腹腔鏡結直腸手術安全可行。
Objective To study the feasibility and curative effect of laparoscopic vs. open radical rectectomy and colectomy for colorectal cancer. Methods Sixty-two cases who underwent laparoscopic operation (17， 2， 10， 23， 9 and 1 case underwent radical right colectomy， radical transverse colectomy， radical left colectomy， Dixon， Miles and Hartmann operation respectively) and 78 cases who underwent open operation (17， 4， 11， 27， 18 and 1 case underwent radical right colectomy， radical transverse colectomy， radical left colectomy， Dixon， Miles and Hartmann operation respectively) in our department from Aug. 2001 to Jun. 2008 were included. The clinical data of patients in two groups were compared. Results There were no severe complications and death occurred in both groups and 4 cases in laparoscopic group were converted to open operation during the procedure. The mean operation time of laparoscopic group and open group were (230.6±23.5) min and (145.5±17.6) min respectively, there was a statistical difference between them (P＜0.01). The intra-operative blood loss of laparoscopic group was obviously less than that in open group 〔(135.5±22.5) ml vs. (300.6±34.5) ml， P＜0.01〕. There was no statistical difference of the number of cleared lymph nodes between two groups 〔(11.8±1.5) pieces vs. (13.3±1.7) pieces， Pgt;0.05〕. The length of distal incision margin of rectal anterior resection in laparoscopic group was obviously longer than that in open group 〔(3.1±0.4) cm vs. (2.6±0.3) cm， P＜0.01〕. The gastrointestinal and urinary function of laparoscopic group recovered more quickly than those in open group 〔(2.3±0.7) d vs. (3.6±0.9) d for intake of liquid diet， P＜0.05； (3.5±1.1) d vs. (4.7±1.2) d for intake of solid diet， P＜0.05； (2.3±0.4) d vs. (4.4±1.2) d for duration of urethral catheterization， P＜0.01， respectively〕. The length of hospital stay in laparoscopic group was shorter than that in open group 〔(8.5±0.7) d vs. (12.8±0.9) d， P＜0.01〕. But the cost of hospitalization in laparoscopic group was higher than that in open group 〔(3.14±0.25)×104 yuan vs. (2.02±0.75)×104 yuan， P＜0.05〕. There was no statistical difference of the three-year survival rate between two groups (89.5% vs. 89.1%， Pgt;0.05). Conclusion Laparoscopic radical rectectomy and colectomy for colorectal cancer is feasible and safe with minimal invasiveness.
In 2022, the National Cancer Center (NCC) of China reported the nationwide statistics of 2016 using population-based cancer registry data from all available cancer registries in China, which was mainly about the cancer incidence and mortality. Cancer remains a major health problem currently in our country and requires long term cooperation to deal with. This article provided a key point interpretation and analysis of cancer prevalence data in China, and provided an analysis of several main risk factors for cancer, which was conducive to the development of cancer prevention and control programs in different regions.
Objective To comprehensively analyze the research trends in the reported outcomes for lung cancer patients and related management, reveal research hotspots and trends, and provide references for future related research. Methods We searched for relevant literature in the Web of Science core collection, PubMed, and Scopus databases from inception to December 31, 2023. CiteSpace bibliometric software was used to analyze the distribution of authors, countries and regions, research institutions, keyword co-occurrence, keyword burst, and to generate keyword clusters and timeline analysis maps. Results A total of 478 qualified publications were included, and the number of published papers showed an overall upward trend. The highest number of articles was published in the United States. The journal with the highest number of articles was Journal of Pain and Symptom Management, and the journal with the highest citation frequency was Journal of Clinical Oncology. The results of keyword burst analysis showed that hot topics mainly focused on areas such as prospective study, physical activity, exercise, vomiting, survival. ConclusionAlthough the research on lung cancer surgical treatment and the management of patients is developing rapidly, the application of management based on reported outcomes of lung cancer patients is still at a nascent stage, and needs to be continuously improved in clinical research and practice. The establishment of relevant assessment systems needs to be improved. In the future, more researchers need to focus on this area, strengthen multi-regional and multi-institutional collaborations, and accelerate research progress in the management of reported outcomes in lung cancer patients.